SurModics Inc.+$0.72 $11.65 A Rodman & Renshaw analyst upgraded the shares to "market perform," saying the share price already reflects the risks the medical technology company is facing. (Ticker: SRDX)
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Abu Ghraib military contractor warned bosses of abuses 2 weeks after arriving, testimony reveals
A civilian contractor sent to work as an interrogator at Iraq's infamous Abu Ghraib prison resigned within two weeks of his arrival and told his corporate bosses that mistreatment of detainees was likely to continue.
Business
Biden vows to shield US steel industry by blocking Japanese merger and seeking new Chinese tariffs
President Joe Biden suggested to cheering, unionized steelworkers on Wednesday that his administration would thwart the acquisition of U.S. Steel by a Japanese company, and he called for a tripling of tariffs on Chinese steel, seeking to use trade policy to win over working-class votes in the battleground state of Pennsylvania.
Business
Georgia's parliament votes to approve so-called 'Russian law' targeting media in first reading
Georgia's parliament has voted in the first reading to approve a proposed law that would require media and non-commercial organizations to register as being under foreign influence if they receive more than 20% of their funding from abroad.
Nation
Jill Biden says an agreement to let federal employee military spouses work from overseas is overdue
Jill Biden said Wednesday that allowing federal employees who are military spouses to work from overseas is a ''national security imperative'' that is long overdue.
Business
An NPR editor who wrote a critical essay on the company has resigned after being suspended
A National Public Radio editor who wrote an essay criticizing his employer for promoting liberal views resigned on Wednesday, attacking NPR's new CEO on the way out.
